Targeting TRPM2 in ROS-Coupled Diseases

Under pathological conditions such as inflammation and ischemia-reperfusion injury large amounts of reactive oxygen species (ROS) are generated which, in return, contribute to the development and exacerbation of disease. The second member of the transient receptor potential (TRP) melastatin subfamil...

Full description

Bibliographic Details
Main Authors: Shinichiro Yamamoto, Shunichi Shimizu
Format: Article
Language:English
Published: MDPI AG 2016-09-01
Series:Pharmaceuticals
Subjects:
Online Access:http://www.mdpi.com/1424-8247/9/3/57